Dhinoth K Bangarusamy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dhinoth K Bangarusamy has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Adaikalavan Ramasamy
Respiratory Epidemiology and Public Health Group, National Heart and Lung Institute, Imperial College London, London, UK
1 shared publication - Ai Li Yeo
Genome Institute of Singapore, Singapore 117528
1 shared publication - Allen Chong
Institute for Infocomm Research, 21 Heng Mui Keng Terrace, Singapore 119613, Singapore
1 shared publication - Anders Ström
Center for Biotechnology, Karolinska Institute, Hälsovägen 7-9, 141 57 Huddinge, Novum, Sweden
1 shared publication - Balraj Doray
Genome Institute of Singapore, Singapore 117528
1 shared publication - Chin-Yo Lin
Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX 77004, USA
1 shared publication
Latest Publications
- Open Access
- 12 August 2004
- Published by Springer Nature in Genome Biology
- Vol. 5 (9) , R66
Discovery of estrogen receptor α target genes and response elements in breast tumor cells
Background: Estrogens and their receptors are important in human development, physiology and disease. In this study, we utilized an integrated genome-wide molecular and computational approach to characterize the interaction between the activated estrogen receptor (ER) and the regulatory elements of candidate target genes. Results: Of around 19,000 genes surveyed in this study, we observed 137 ER-regulated genes in T-47D cells, of which only 89 were direct target genes. Meta-analysis of heterogeneous in vitro and in vivo datasets showed that the expression profiles in T-47D and MCF-7 cells are remarkably similar and overlap with genes differentially expressed between ER-positive and ER-negative tumors. Computational analysis revealed a significant enrichment of putative estrogen response elements (EREs) in the cis-regulatory regions of direct target genes. Chromatin immunoprecipitation confirmed ligand-dependent ER binding at the computationally predicted EREs in our highest ranked ER direct target genes, NRIP1, GREB1 and ABCA3. Wider examination of the cis-regulatory regions flanking the transcriptional start sites showed species conservation in mouse-human comparisons in only 6% of predicted EREs. Conclusions: Only a small core set of human genes, validated across experimental systems and closely associated with ER status in breast tumors, appear to be sufficient to induce ER effects in breast cancer cells. That cis-regulatory regions of these core ER target genes are poorly conserved suggests that different evolutionary mechanisms are operative at transcriptional control elements than at coding regions. These results predict that certain biological effects of estrogen signaling will differ between mouse and human to a larger extent than previously thought.
- 12 August 2004
- Published by Springer Nature in Genome Biology
- Vol. 5 (9) , R66
Open AccessDiscovery of estrogen receptor α target genes and response elements in breast tumor cells
Background: Estrogens and their receptors are important in human development, physiology and disease. In this study, we utilized an integrated genome-wide molecular and computational approach to characterize the interaction between the activated estrogen receptor (ER) and the regulatory elements of candidate target genes. Results: Of around 19,000 genes surveyed in this study, we observed 137 ER-regulated genes in T-47D cells, of which only 89 were direct target genes. Meta-analysis of heterogeneous in vitro and in vivo datasets showed that the expression profiles in T-47D and MCF-7 cells are remarkably similar and overlap with genes differentially expressed between ER-positive and ER-negative tumors. Computational analysis revealed a significant enrichment of putative estrogen response elements (EREs) in the cis-regulatory regions of direct target genes. Chromatin immunoprecipitation confirmed ligand-dependent ER binding at the computationally predicted EREs in our highest ranked ER direct target genes, NRIP1, GREB1 and ABCA3. Wider examination of the cis-regulatory regions flanking the transcriptional start sites showed species conservation in mouse-human comparisons in only 6% of predicted EREs. Conclusions: Only a small core set of human genes, validated across experimental systems and closely associated with ER status in breast tumors, appear to be sufficient to induce ER effects in breast cancer cells. That cis-regulatory regions of these core ER target genes are poorly conserved suggests that different evolutionary mechanisms are operative at transcriptional control elements than at coding regions. These results predict that certain biological effects of estrogen signaling will differ between mouse and human to a larger extent than previously thought.